Staging of the mediastinum: Value of positron emission tomography imaging in non-small cell lung cancer

European Respiratory Journal

Volumn 9, Issue 12, 1996, Pages 2560-2564

  Bury, Th ^a,c   Paulus, P ^a   Dowlati, A ^a   Corhay, J L ^a   Weber, T ^a   Ghaye, B ^a   Schoffers, J ^a,b   Limet, R ^a   Albert, A ^a   Rigo, P ^a   Radermecker, M ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b CHR   (Belgium)

^c CHU SART TILMAN   (Belgium)

Author keywords

computed tomography scan; mediastinum staging; non small lung cancer; positron emission tomography scan

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; HUMAN; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MEDIASTINUM; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

EID: 10544222428     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.96.09122560     Document Type: Article

References (26)

1. Minna JD, Higgins GA, Glatstein EJ. Cancer of the lung. In: Cancer Principles and Practice of Oncology. Philadelphia, PA, Lippincott, 1985;pp. 507-597.
2. Shields TW. The significance of ipsilateral mediastinal lymph node metastasis (N2 disease) in non-small cell carcinoma of the lung. Thorac Cardiovasc Surg 1990;99: 48-53.
3. Me Loud T, Bourgouin P, Greenberg R, et al. Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling. Radiology 1992;182: 319-323.
4. Musset D, Grenier P, Carette MF, et al. Primary lung cancer staging: prospective comparative study of MR imaging with CT. Radiology 1986;160: 607-611.
5. Georgian D, Rice T, Metha A, Wiedemann H, Stoller J, O'Donovan P. Intrathoracic lymph node evaluation by CT and MRI with histopathologic correlation in non-small cell bronchogenic carcinoma. Clin Imaging 1990;14: 35-40.
6. Webb R, Gatsonis C, Zerhouni E, et al. CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the radiologic diagnostic oncology group. Radiology 1991;178: 705-713.
7. Hawkins R, Hoh C, Dahlbom M et al. PET cancer evaluations with FDG. J Nucl Med 1991;32: 1555-1558.
8. Rego S, Hoh C, Glaspy J, Aberle D, et al. Imaging of pulmonary mass lesions with whole-body positron emission tomography and fluorodeoxyglucose. Cancer 1993;72: 82-90.
9. Warburg O. On the origin of cancer cells. Science 1956;123: 309-314.
10. Nolop K, Rhodes C, Brudin H, et al. Glucose utilization in vivo by human pulmonary neoplasms. Cancer 1987;60: 2682-2689.
11. Fujiwara T, Matsuzawa T, Kubota K, et al. Relationship between histologic type of primary lung cancer and carbon-11-L-methionine uptake with PET. J Nucl Med 1989;30: 33-37.
12. Gupta N, Frank A, Dewan N, et al. Solitary pulmonary nodules: detection of malignancy with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 1992;184: 441-444.
13. Dewan N, Gupta N, Redepenning L, Phallen J, Frick M. Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Chest 1993;104: 997-1002.
14. Bury T, Paulus P, Corhay JL, et al. Apport diagnostique de la tomographie àémission de positons dans l'évaluation d'une opacitépulmonaire unique: étude préliminaire chez 30 patients. Med Nucl 1996;20: 77-82.
15. Tisi G, Friedman P, Peters R, et al. Clinical staging of primary lung cancer. Am Rev Respir Dis 1983;127: 659-664.
16. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas 1960;20: 37-46.
17. Baron R, Levitt R, Sagel S, White M, Roper C, Marbarger J. Computed tomography in the preoperative evaluation of bronchogenic carcinoma. Radiology 1982;145: 727-732.
18. Dillemans B, Deneffe G, Verschakelen J, Decramer M. Value of computed tomography and mediastinoscopy in preoperative evaluation of mediastinal nodes in non-small cell lung cancer. Eur J Cardio Thorac Surg 1994;8: 37-42.
19. Patterson G, Ginsberg R, Poon P, et al. A prospective evaluation of magnetic resonance imaging, computed tomography and mediastinoscopy in the preoperative assessment of mediastinal node status in bronchogenic carcinoma. J Thorac Cardiovasc Surg 1987;94: 679-684.
20. Grenier Ph, Dubray B, Carette M, Frija G, Musset D, Chastang C. Preoperative thoracic staging of lung cancer: CT and MR evaluation. Diagn Interv Radiol 1989;1: 23-28.
21. Libshitz H, McKenna R. Mediastinal lymph node size in lung cancer. Am J Roentgenol 1984;143: 715-718.
22. McKenna R, Libshitz H, Moutain C, McMurtrey M. Roentgenographic evaluation of mediastinal nodes for preoperative assessment in lung cancer. Chest 1985;88: 206-210.
23. Kubota K, Matsuzawa T, Fujiwara T, et al. Differential diagnosis of lung tumor with positron emission tomography: a prospective study. J Nucl Med 1990;31: 1927-1933.
24. Wahl R, Hutchins G, Buchsbaum D, Liebert M, Grossman B, Fisher S. 18-F-2-deoxy-2-fluoro-o-glucose uptake into human tumor xenografts: feasibility studies for cancer imaging with positron emission tomography. Cancer 1991;67: 1544-1550.
25. Wahl R, Quint L, Greenough R, Meyer C, White R, Orringer M. Staging of mediastinal non-small cell lung cancer with FDG-PET, CT and fusion images: prospective preliminary evaluation. Radiology 1994;191: 371-377.
26. Chin R, Ward R, Keyes J, et al. Mediastinal staging of non-small cell lung cancer with positron emission tomography. Am J Respir Crit Care Med 1995;152: 2090-2096.